indium In 111-DOTA-h11B6
Term · Oncology and biomedicine · MLC-T-ONC-014433
A radioimmunoconjugate containing the recombinant immunoglobulin G1 (IgG1) kappa humanized monoclonal antibody h11B6 that targets human kallikrein-2 (HK2) conjugated with the bifunctional, macrocyclic chelating agent tetra-azacyclododecanetetra-acetic acid (DOTA) and labeled with the radioisotope indium In 111, with potential use as an imaging agent. Upon administration of indium In 111-DOTA-h11B6, the h11B6 moiety targets and binds to HK2. Upon binding and radioimaging, HK2-expressing tumor cells can be visualized and the binding of h11B6 can be assessed. HK2 is overexpressed on a variety of cancer cells.
| Identifier | MLC-T-ONC-014433 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 111In-DOTA-h11B6; indium-111 radiolabeled h11B6 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014433",
"term": "indium In 111-DOTA-h11B6",
"field": "Oncology and biomedicine",
"definition": "A radioimmunoconjugate containing the recombinant immunoglobulin G1 (IgG1) kappa humanized monoclonal antibody h11B6 that targets human kallikrein-2 (HK2) conjugated with the bifunctional, macrocyclic chelating agent tetra-azacyclododecanetetra-acetic acid (DOTA) and labeled with the radioisotope indium In 111, with potential use as an imaging agent. Upon administration of indium In 111-DOTA-h11B6, the h11B6 moiety targets and binds to HK2. Upon binding and radioimaging, HK2-expressing tumor cells can be visualized and the binding of h11B6 can be assessed. HK2 is overexpressed on a variety of cancer cells.",
"synonyms": [
"111In-DOTA-h11B6",
"indium-111 radiolabeled h11B6"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/indium-in-111-dota-h11b6/"
}
Record 9,205 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.